KRAS and neoplasm: Each patient’s sex, age, genetic mutation status (BRAF, NRAS, KRAS), and MSI status based on tumor genetic profiling; location of the primary tumor; site of metastasis; and time from diagnosis to death were collected from the hospital information system.